EE164 Cost-Effectiveness of Inclisiran as Add-on Therapy to Standard-of-Care for the Secondary Prevention of Cardiovascular Events in Patients with Elevated LDL Cholesterol
Abstract
Authors
M. Wong J.Q.P. Lim L.E. Tan M.I. Abdul Aziz S.K.B. Ong K. Ng